Foudil Lamari

1.3k total citations
27 papers, 814 citations indexed

About

Foudil Lamari is a scholar working on Molecular Biology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Foudil Lamari has authored 27 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Physiology and 12 papers in Psychiatry and Mental health. Recurrent topics in Foudil Lamari's work include Alzheimer's disease research and treatments (13 papers), Dementia and Cognitive Impairment Research (11 papers) and Cholesterol and Lipid Metabolism (4 papers). Foudil Lamari is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Dementia and Cognitive Impairment Research (11 papers) and Cholesterol and Lipid Metabolism (4 papers). Foudil Lamari collaborates with scholars based in France, Italy and Germany. Foudil Lamari's co-authors include Bruno Dubois, Marie Sarazin, Leonardo Cruz de Souza, Simone Lista, Harald Hampel, Stéphane Epelbaum, Michel Bottlaender, Maxime Bertoux, Olivier Colliot and Marie Chupin and has published in prestigious journals such as Brain, Biological Psychiatry and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Foudil Lamari

27 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Foudil Lamari France 17 415 367 215 151 144 27 814
Britta Brix Germany 17 617 1.5× 484 1.3× 264 1.2× 149 1.0× 268 1.9× 25 1.2k
Bradley B. Miller United States 12 464 1.1× 312 0.9× 206 1.0× 150 1.0× 121 0.8× 20 882
Amber Nolan United States 14 251 0.6× 167 0.5× 166 0.8× 69 0.5× 236 1.6× 31 727
Alessandro Salviati Italy 16 622 1.5× 411 1.1× 351 1.6× 105 0.7× 230 1.6× 45 1.3k
Dolly Reyes‐Dumeyer United States 14 516 1.2× 254 0.7× 311 1.4× 41 0.3× 66 0.5× 45 835
Vladimiro Pietrini Italy 17 341 0.8× 149 0.4× 325 1.5× 163 1.1× 240 1.7× 43 1.1k
Hans H. Klünemann Germany 13 373 0.9× 134 0.4× 136 0.6× 67 0.4× 130 0.9× 25 821
Isabelle Miederer Germany 11 256 0.6× 186 0.5× 151 0.7× 107 0.7× 123 0.9× 26 783
Ashley Cannon United States 18 745 1.8× 320 0.9× 302 1.4× 131 0.9× 770 5.3× 38 1.5k
Martha Foiani United Kingdom 18 408 1.0× 211 0.6× 312 1.5× 47 0.3× 256 1.8× 23 855

Countries citing papers authored by Foudil Lamari

Since Specialization
Citations

This map shows the geographic impact of Foudil Lamari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Foudil Lamari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Foudil Lamari more than expected).

Fields of papers citing papers by Foudil Lamari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Foudil Lamari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Foudil Lamari. The network helps show where Foudil Lamari may publish in the future.

Co-authorship network of co-authors of Foudil Lamari

This figure shows the co-authorship network connecting the top 25 collaborators of Foudil Lamari. A scholar is included among the top collaborators of Foudil Lamari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Foudil Lamari. Foudil Lamari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villain, Nicolas, Rita Azevedo, Susana Boluda, et al.. (2024). Evaluation of SP3 for antibody-free quantification of tau in CSF mimic and brain by mass spectrometry. European Journal of Mass Spectrometry. 30(1). 65–75. 1 indexed citations
2.
Bahloul, Z., et al.. (2022). Selected plasma oxysterols as a potential multi-marker biosignature panel for Behçet’s Disease. The Journal of Steroid Biochemistry and Molecular Biology. 221. 106122–106122. 5 indexed citations
3.
Fernández‐Eulate, Gorka, P. Dureau, Anaïs Brassier, et al.. (2022). Prospective cholestanol screening of cerebrotendinous xanthomatosis among patients with juvenile-onset unexplained bilateral cataracts. Orphanet Journal of Rare Diseases. 17(1). 434–434. 2 indexed citations
4.
Naifar, Manel, et al.. (2022). Plasma oxysterols in drug-free patients with schizophrenia. The Journal of Steroid Biochemistry and Molecular Biology. 221. 106123–106123. 8 indexed citations
5.
Naifar, Manel, et al.. (2021). Plasma oxysterols: Altered level of plasma 24-hydroxycholesterol in patients with bipolar disorder. The Journal of Steroid Biochemistry and Molecular Biology. 211. 105902–105902. 21 indexed citations
6.
Koht, Jeanette, et al.. (2020). Elevated hydroxycholesterols in Norwegian patients with hereditary spastic paraplegia SPG5. Journal of the Neurological Sciences. 419. 117211–117211. 4 indexed citations
7.
Chaussenot, Annabelle, Gérard Besson, Foudil Lamari, et al.. (2019). Cholic acid as a treatment for cerebrotendinous xanthomatosis in adults. Journal of Neurology. 266(8). 2043–2050. 30 indexed citations
8.
9.
Migliaccio, Raffaella, Foudil Lamari, Sophie Ferrieux, et al.. (2018). Parietal Involvement in the Semantic Variant of Primary Progressive Aphasia with Alzheimer’s Disease Cerebrospinal Fluid Profile. Journal of Alzheimer s Disease. 66(1). 271–280. 3 indexed citations
10.
Janel, Nathalie, Panagiotis Alexopoulos, Anne Badel, et al.. (2017). Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer’s disease. Translational Psychiatry. 7(6). e1154–e1154. 27 indexed citations
11.
Lista, Simone, Nicola Toschi, Filippo Baldacci, et al.. (2017). Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease. Neurochemistry International. 108. 355–360. 44 indexed citations
12.
Baldacci, Filippo, Nicola Toschi, Simone Lista, et al.. (2017). Two‐level diagnostic classification using cerebrospinal fluid YKL‐40 in Alzheimer's disease. Alzheimer s & Dementia. 13(9). 993–1003. 38 indexed citations
13.
Epelbaum, Stéphane, Rémy Genthon, Enrica Cavedo, et al.. (2017). Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept. Alzheimer s & Dementia. 13(4). 454–467. 59 indexed citations
14.
Sepúlveda-Díaz, Julia E., Seyedeh Maryam Alavi Naini, Minh Bao Huynh, et al.. (2015). HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer’s disease-related tau pathology. Brain. 138(5). 1339–1354. 77 indexed citations
15.
Bertoux, Maxime, Leonardo Cruz de Souza, Fabian Corlier, et al.. (2013). Two Distinct Amnesic Profiles in Behavioral Variant Frontotemporal Dementia. Biological Psychiatry. 75(7). 582–588. 73 indexed citations
16.
Kas, Aurélie, Olga Uspenskaya, Foudil Lamari, et al.. (2012). Distinct brain perfusion pattern associated with CSF biomarkers profile in primary progressive aphasia. Journal of Neurology Neurosurgery & Psychiatry. 83(7). 695–698. 17 indexed citations
17.
Dorothée, Guillaume, Michel Bottlaender, Leonardo Cruz de Souza, et al.. (2012). Distinct Patterns of Antiamyloid-β Antibodies in Typical and Atypical Alzheimer Disease. Archives of Neurology. 69(9). 1181–5. 17 indexed citations
18.
Souza, Leonardo Cruz de, Marie Chupin, Foudil Lamari, et al.. (2011). CSF tau markers are correlated with hippocampal volume in Alzheimer's disease. Neurobiology of Aging. 33(7). 1253–1257. 84 indexed citations
19.
Habert, Marie‐Odile, Leonardo Cruz de Souza, Foudil Lamari, et al.. (2009). Brain perfusion SPECT correlates with CSF biomarkers in Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 37(3). 589–593. 16 indexed citations
20.
Deguin, Brigitte, et al.. (2003). Homochiral rigid γ-amino acid glycosides from aucubin. Tetrahedron Asymmetry. 14(9). 1083–1086. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Britta Brix Breakdown of academic impact, for papers by Bradley B. Miller Breakdown of academic impact, for papers by Amber Nolan Breakdown of academic impact, for papers by Alessandro Salviati Breakdown of academic impact, for papers by Dolly Reyes‐Dumeyer Breakdown of academic impact, for papers by Vladimiro Pietrini Breakdown of academic impact, for papers by Hans H. Klünemann Breakdown of academic impact, for papers by Isabelle Miederer Breakdown of academic impact, for papers by Ashley Cannon Breakdown of academic impact, for papers by Martha Foiani
Rankless by CCL
2026